Intuniv XR (guanfacine hydrochloride)
Status:
Negotiations were not pursued
Manufacturer:
Shire Pharma Canada ULC
Indication:
Attention-deficit/hyperactivity disorder (ADHD)
Last updated November 18, 2014
Status:
Negotiations were not pursued
Manufacturer:
Merck Canada Inc.
Indication:
Allergy
Last updated October 30, 2014
Status:
Concluded with an LOI
Manufacturer:
Alcon Canada Inc.
Indication:
Vitreomacular Adhesion
Last updated October 10, 2014
Status:
Concluded with an LOI
Manufacturer:
Alexion Pharma Canada Corp.
Indication:
Paroxysmal nocturnal hemoglobinuria (PNH)
Last updated October 5, 2014
Status:
Concluded with an LOI
Manufacturer:
Sanofi Genzyme Canada
Indication:
Multiple Sclerosis, Relapsing
Last updated September 26, 2014
Status:
Negotiations were not pursued
Manufacturer:
Regeneron
Indication:
Metastatic Colorectal Cancer
Last updated September 25, 2014
Status:
Concluded with an LOI
Manufacturer:
Bristol Myers Squibb Canada Inc.
Indication:
Rheumatoid Arthritis
Last updated September 10, 2014
Status:
Concluded with an LOI
Manufacturer:
Janssen Inc.
Indication:
Chronic Hepatitis C
Last updated August 20, 2014
Status:
Concluded with an LOI
Manufacturer:
Hoffmann-La Roche Ltd.
Indication:
Pulmonary fibrosis (idiopathic, mild to moderate)
Last updated August 15, 2014
Status:
Concluded with an LOI
Manufacturer:
Bayer Inc.
Indication:
Gastrointestinal Stromal Tumours
Last updated August 11, 2014